Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1604 studies found for:    "Carcinoma, Squamous Cell"
Show Display Options
Rank Status Study
1 Unknown  Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)
Condition: Carcinoma, Squamous Cell
Intervention: Drug: infusions of Panitumumab
2 Recruiting Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynx
Condition: Carcinoma, Squamous Cell
Intervention: Procedure: Neck Dissection
3 Terminated An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Condition: Carcinoma, Squamous Cell
Intervention: Drug: Cetuximab
4 Completed Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)
Condition: Carcinoma, Squamous Cell
Intervention: Procedure: hyperfractionated accelerated radiotherapy
5 Not yet recruiting Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin
Condition: Carcinoma, Squamous Cell
Intervention: Drug: Pembrolizumab
6 Recruiting A Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.
Condition: Carcinoma, Squamous Cell
Interventions: Procedure: Resection for primary lesion and cervical lymph node dissection;   Procedure: Resection for primary lesion
7 Unknown  Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenols
Condition: Carcinoma, Squamous Cell
Interventions: Drug: Aspirin;   Dietary Supplement: Tea Polyphenols
8 Completed Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
Condition: Squamous Cell Carcinoma
Intervention:
9 Recruiting Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma
Conditions: Squamous Cell Carcinoma of Skin;   Carcinoma, Squamous Cell
Interventions: Drug: Pegylated Interferon alpha-2b;   Drug: Capecitabine;   Drug: 5-FU
10 Withdrawn Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
Condition: Carcinoma, Squamous Cell
Interventions: Drug: olaparib;   Drug: cisplatin;   Radiation: Intensity Modulated Radiotherapy
11 Terminated Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus
Condition: Carcinoma, Squamous Cell
Intervention: Drug: bivatuzumab mertansine
12 Completed Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ
Condition: Carcinoma, Squamous Cell
Intervention: Drug: PEP005
13 Recruiting Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck
Conditions: Carcinoma, Squamous Cell;   Carcinoma, Squamous Cell of Head and Neck
Intervention: Drug: Intraarterial Cetxuimab (Erbitux)
14 Completed Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancer
Condition: Squamous Cell Cancer
Intervention: Drug: proflavine
15 Active, not recruiting Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx
Condition: Squamous Cell Carcinoma
Interventions: Drug: fluorine F18 EF5;   Procedure: immunohistochemistry staining method;   Procedure: biopsy;   Procedure: Positron Emission tomography
16 Unknown  Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Interventions: Drug: Nedaplatin;   Drug: Cisplatin;   Drug: Docetaxel
17 Active, not recruiting Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer
Condition: Skin Squamous Cell Cancer
Intervention: Drug: Dacomitinib
18 Terminated Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)
Conditions: Carcinoma, Squamous Cell;   Head and Neck Neoplasms
Intervention: Drug: Farnesyl Protein Transferase Inhibitor
19 Completed
Has Results
Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
Condition: Squamous Cell Carcinoma
Intervention: Drug: Erlotinib
20 Completed A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck
Conditions: Head and Neck Neoplasms;   Carcinoma, Squamous Cell
Intervention: Drug: ARQ 501

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.